| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/1999 | CA2301162A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin |
| 03/25/1999 | CA2300076A1 Organ specific nutrition |
| 03/25/1999 | CA2296045A1 Persephin and related growth factors |
| 03/25/1999 | CA2247952A1 Process for preparing optically active 2-amino-w-oxoalkanoic acid derivatives |
| 03/25/1999 | CA2244978A1 Novel alcohol dehydrogenase |
| 03/25/1999 | CA2244971A1 Mure |
| 03/25/1999 | CA2244967A1 Murf |
| 03/25/1999 | CA2244954A1 Murf |
| 03/25/1999 | CA2216559A1 G2 checkpoint inhibitors and assay |
| 03/24/1999 | EP0903409A2 Aminopeptidase (AmpS) |
| 03/24/1999 | EP0903407A2 Streptococcus pneumoniae phoH gene |
| 03/24/1999 | EP0903406A1 Modulation of gene expression through interference with RNA secondary structure |
| 03/24/1999 | EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them |
| 03/24/1999 | EP0903349A2 CCR-3 receptor antagonists |
| 03/24/1999 | EP0903348A1 Epothilone derivatives, preparation and utilization |
| 03/24/1999 | EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid |
| 03/24/1999 | EP0903344A1 Quinazolin-4-one derivatives, their preparation and their use as hair growth promoters or in external compositions for skin |
| 03/24/1999 | EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments |
| 03/24/1999 | EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 03/24/1999 | EP0903148A2 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 03/24/1999 | EP0903146A1 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid |
| 03/24/1999 | EP0903145A2 Pharmaceutical composition for skin disorders |
| 03/24/1999 | EP0903143A2 Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels |
| 03/24/1999 | EP0902839A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 03/24/1999 | EP0902837A1 Tailless nuclear hormone receptor (tlx receptor) |
| 03/24/1999 | EP0902836A1 Asymmetric hammerhead ribozymes |
| 03/24/1999 | EP0902835A1 Purification of pharmaceutical-grade plasmid dna |
| 03/24/1999 | EP0902832A1 Anol esters as bleach activators for detergents and cleaners |
| 03/24/1999 | EP0902791A1 Extracellular/epidermal growth factor hcaba58x |
| 03/24/1999 | EP0902790A1 Process for preparing steroids having a carboxamide side-chain |
| 03/24/1999 | EP0902789A1 Androstene derivatives |
| 03/24/1999 | EP0902783A1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 03/24/1999 | EP0902782A1 Urea derivatives as inhibitors of impdh enzyme |
| 03/24/1999 | EP0902781A1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 03/24/1999 | EP0902780A1 Quaternary cytofectins |
| 03/24/1999 | EP0902779A2 Phosphate mimics |
| 03/24/1999 | EP0902777A1 D-mannitol and its preparation |
| 03/24/1999 | EP0902687A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/24/1999 | EP0902685A1 Ultramicro-emulsions of spontaneously dispersible concentrates containing antitumorally, antivirally and antiparasitically active esters of pentacyclic triterpenes |
| 03/24/1999 | EP0902684A1 Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs |
| 03/24/1999 | EP0902683A1 AGONISTS IN THE COSTIMULATION OF TcR/CD3-INDUCED T-LYMPHOCYTES |
| 03/24/1999 | EP0902682A2 Cationic virosomes as transfer system for genetic material |
| 03/24/1999 | EP0902681A1 Inhibition of selectin binding |
| 03/24/1999 | EP0902680A1 Reparation and prevention of fibrotic lesions |
| 03/24/1999 | EP0902665A1 Dietary phytoestrogen in estrogen replacement therapy |
| 03/24/1999 | EP0902664A1 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 03/24/1999 | EP0902624A1 Composition and its use as a food supplement or for lowering lipids in serum |
| 03/24/1999 | EP0810878B1 Rna photocleavage using texaphyrins |
| 03/24/1999 | EP0784619B1 Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives |
| 03/24/1999 | EP0745063B1 Substituted biphenyl derivatives as phosphodiesterase inhibitors |
| 03/24/1999 | EP0716650B1 Indole and indoline derivatives as 5ht1d receptor antagonists |
| 03/24/1999 | EP0673240B1 Stabilized medicinal aerosol solution formulations |
| 03/24/1999 | EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 03/24/1999 | EP0664786B1 Arginine keto-amide enzyme inhibitors |
| 03/24/1999 | EP0640085B1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists |
| 03/24/1999 | EP0598046B1 Cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 03/24/1999 | EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 03/24/1999 | EP0560937B1 Pharmaceutical compositions |
| 03/24/1999 | EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 03/24/1999 | CN1212055A Systems and method for quantifying photoreactions in light activated materials |
| 03/24/1999 | CN1212016A Recombinant ribonuclease proteins |
| 03/24/1999 | CN1211991A Compounds with growth hormone releasing properties |
| 03/24/1999 | CN1211990A Isoquinolines useful as analgesics |
| 03/24/1999 | CN1211989A Composition and method for delivery of nucleic acids |
| 03/24/1999 | CN1211987A Camptothecin derivatives and use thereof as antimutor agents |
| 03/24/1999 | CN1211985A Fused imidazole derivatives as multidrug resistance modulators |
| 03/24/1999 | CN1211984A Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| 03/24/1999 | CN1211983A Azabicyclic esters of carbamic acids useful in therapy |
| 03/24/1999 | CN1211982A Tropane derivatives, their preparation and use |
| 03/24/1999 | CN1211981A Oxa-and thia-diazole muscarinic receptor antagonists |
| 03/24/1999 | CN1211974A Quinoline-2-(1H)-ones |
| 03/24/1999 | CN1211938A Solid and semi-solid hydrocarbon gels and use thereof |
| 03/24/1999 | CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 03/24/1999 | CN1211925A Use of ginkgo biloba extracts for preparation of pharmaceutical compositions and method of cosmetic treatment using ginkgo biloba extract |
| 03/24/1999 | CN1211924A Immunomodulatory complex for helicobacter bacteria |
| 03/24/1999 | CN1211923A Ligands to enhance cellular uptake of biomolecules |
| 03/24/1999 | CN1211922A Associations of active principles containing clopidogrel and antithrombotic agent |
| 03/24/1999 | CN1211921A Benzothiophenes, formulations containing same and process of preparing same |
| 03/24/1999 | CN1211920A Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis |
| 03/24/1999 | CN1211919A Radiosensitizing taxanes and their pharmaceutical preparations |
| 03/24/1999 | CN1211918A TNF－α转变酶 TNF-α converting enzyme |
| 03/24/1999 | CN1211917A Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 03/24/1999 | CN1211575A Novel compound |
| 03/24/1999 | CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists |
| 03/24/1999 | CN1211569A Substituted quinolone derivatives and pharmaceuticals containing the same |
| 03/24/1999 | CN1211421A Medicament for preventing and curing several fish diseases |
| 03/24/1999 | CN1211419A Cell renewal rate compositions |
| 03/24/1999 | CN1042633C Alkoxy alkyl carbamates from imidazo (1,2-a) pyridines |
| 03/24/1999 | CN1042632C Pyridone carboxylic acid derivatives, intermediate and pharmaceutical composition for preparing same |
| 03/24/1999 | CN1042631C Substituted salicylic acids, its medicinal composition and use |
| 03/24/1999 | CN1042598C Antitussive and expectorant preparation consisting of codeine and root of ballon flower |
| 03/24/1999 | CA2247733A1 The use of an inhibitor of the na+/h+ exchanger for the production of a medicament for the treatment or prophylaxis of disturbances of the central nervous system |
| 03/23/1999 | US5886184 Finasteride processes |
| 03/23/1999 | US5886180 25-methylene and 24-25 -epoxy marcfortines and paraherquamides |
| 03/23/1999 | US5886179 Nucleotide analogs |
| 03/23/1999 | US5886178 3-aroylbenzylpyridazinone derivatives |
| 03/23/1999 | US5886177 Phosphate linked oligomers |
| 03/23/1999 | US5886175 Tetracycline antibiotics |
| 03/23/1999 | US5886172 Oral prodrug readily absorped in the digestive tract and hydrolyzed; bioavailabiity; strong antibacterial activity especially against staphylococcus; streptococcus, klebsiella and proteus |
| 03/23/1999 | US5886150 Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof |